Lifecore Biomedical (LFCR) Scheduled to Post Earnings on Thursday

Lifecore Biomedical (NASDAQ:LFCRGet Rating) is scheduled to release its earnings data before the market opens on Thursday, June 1st. Analysts expect Lifecore Biomedical to post earnings of ($0.13) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Lifecore Biomedical Stock Performance

LFCR opened at $8.36 on Thursday. The business’s 50 day simple moving average is $4.19. The firm has a market cap of $253.48 million, a P/E ratio of -3.34 and a beta of 1.07. Lifecore Biomedical has a 1 year low of $1.52 and a 1 year high of $11.95.

Analyst Ratings Changes

LFCR has been the subject of a number of research analyst reports. Stephens downgraded shares of Lifecore Biomedical from an “overweight” rating to an “equal weight” rating in a research report on Monday, March 20th. Barrington Research increased their target price on shares of Lifecore Biomedical from $8.00 to $10.00 in a research report on Wednesday.

About Lifecore Biomedical

(Get Rating)

Lifecore Biomedical, Inc engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Lifecore, Curation Foods, and Others. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans.

Featured Articles

Earnings History for Lifecore Biomedical (NASDAQ:LFCR)

Receive News & Ratings for Lifecore Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifecore Biomedical and related companies with's FREE daily email newsletter.